VRX Silica Offers 1 for 5 Shares at $0.04 with Attaching Options

VRX Silica has kicked off a $6.23 million renounceable entitlement offer, underwritten to $2 million, to fund key development activities at its Arrowsmith North silica sand project including a strategic property purchase and engineering works.

  • Pro-rata renounceable entitlement offer at $0.04 per share
  • Offer includes free attaching options exercisable at $0.10
  • Underwritten to $2 million by Mahe Capital Pty Ltd
  • Funds earmarked for Arrowsmith North project development and Arramall property acquisition
  • Offer excludes shareholders outside Australia, New Zealand, Germany, and UK
An image related to Vrx Silica Limited
Image © middle. Logo © respective owner.

Capital Raise to Propel Arrowsmith North Development

VRX Silica Limited (ASX:VRX) has launched a pro-rata renounceable entitlement offer aiming to raise up to $6.23 million through the issue of one new share for every five shares held at an offer price of $0.04 each. Eligible shareholders will also receive one free attaching option for every two shares subscribed, exercisable at $0.10 and expiring in June 2028. The offer is underwritten to $2 million by Mahe Capital Pty Ltd, which will also receive underwriting options as part of the arrangement.

The capital raising is designed to fund critical next steps in VRX’s flagship Arrowsmith North silica sand project, including early works, final engineering, and the acquisition of the adjacent Arramall property to relocate processing infrastructure. The company plans to allocate up to $2.5 million towards the Arramall purchase, which is pivotal for its environmental offset strategy and project logistics.

Offer Details and Shareholder Impact

The entitlement offer ratio is one share for every five held, with fractional entitlements rounded up. If fully subscribed, approximately 156 million new shares and 77.9 million attaching options will be issued, increasing the total shares on issue to nearly 935 million and options to over 131 million. The offer timetable runs from late May through to mid-June 2026, with rights trading on ASX from 1 June to 12 June.

Shareholders who do not participate face dilution of approximately 16.67% on their shareholding, increasing to about 22.86% if attaching and underwriting options are exercised. The company stresses the offer is highly speculative and urges shareholders to consider the dilution and risks carefully. The directors recommend full participation and have committed to taking up their own entitlements.

Funding Allocation and Project Progress

Proceeds from the offer will primarily support the Arrowsmith North project, including $500,000 for early works, $300,000 for detailed engineering, $1 million for long lead items, and $1.22 million for working capital. The acquisition of the Arramall property, due to settle by 28 July 2026, is central to relocating the processing plant and infrastructure from native bushland, subject to environmental approvals. Delays or failure to secure these approvals could materially affect project timelines.

The company’s recent updated Bankable Feasibility Study for Arrowsmith North highlighted a robust project with an ungeared NPV8 of A$179 million and binding offtake contracts for nearly 1 million tonnes annually, underscoring the strategic importance of progressing development capital.Arrowsmith North BFS Update

Underwriting and Market Considerations

Mahe Capital Pty Ltd acts as both underwriter and lead manager, with fees including a 5% underwriting fee and options issued as incentives. The underwriter has discretion over the allocation of any shortfall securities, ensuring no single party exceeds a 19.9% voting power post-offer. The offer excludes shareholders with registered addresses outside Australia, New Zealand, Germany, and the UK due to regulatory constraints.

VRX’s recent capital raising history includes a $2.1 million placement in late 2025 to fund pre-construction activities and binding offtake contracts secured with reputable Asian customers, reinforcing the company’s path to production.$2.1M Capital Raising The appointment of Tony Swiericzuk as CEO further signals VRX’s commitment to advancing Arrowsmith North towards commercial production.New CEO Appointment

Risks and Uncertainties

The company outlines a comprehensive risk profile including dilution, environmental approvals, operational challenges, market demand fluctuations, and funding uncertainties. Environmental approvals remain a key variable, with the company seeking amendments to conditions that could delay project progress if not granted. The risk of not satisfying offtake contract conditions by the end of 2026 also poses potential setbacks.

VRX cautions that the offer is highly speculative and that the market price of shares post-offer may differ materially from the last traded price of $0.041. Investors should consider their financial situation and seek professional advice before participating.

Bottom Line?

VRX’s $6.23 million rights issue aims to fuel Arrowsmith North’s critical development phase but hinges on environmental approvals and full subscription to avoid dilution and delays.

Questions in the middle?

  • Will the company secure timely environmental approvals for the Arramall property relocation?
  • How will the underwriting shortfall allocation impact shareholder control and dilution?
  • Can VRX meet the conditions precedent for its major offtake contracts by the end of 2026?